Oncology
Cassian Yee, MD
Professor, Department of Melanoma Medical Oncology; Professor, Department of Immunology; Director, Department of Program for T Cell-Based Therapies (ProTCT), Division of Cancer Medicine
Cassian Yee, MD, is a professor in the Department of Melanoma Medical Oncology and Department of Immunology at The University of Texas MD Anderson Cancer Center in Houston, Texas. He serves as Director of the Program for T Cell-Based Therapies (ProTCT), Director of the Solid Tumor Cell Therapy Program, and Co-Director of the Adoptive Cellular Therapy Platform. A pioneer in adoptive cellular therapy, Dr. Yee specializes in isolating rare tumor antigen-specific T cells from peripheral blood, manip
40+
Years in Practice
Credentials
Education & Training
- University of Manitoba — M.D., 1986
- 1987-1989 General Comprehensive Internship, St. Michael's Hospital, Toronto
- 1987-1989 Medical Research Council of Canada Fellow, Ontario Cancer Institute/Princess Margaret Hospital, Toronto
- 1989-1991 Clinical Residency, Internal Medicine, Stanford University Medical Center, Stanford, California
- 1991-1994 Research Fellowship, University of Washington/Fred Hutchinson Cancer Research Center, Seattle, Washington
Recognition & Leadership
Awards & Honors
- 2022-Present Kenneth D. Muller Professorship in Melanoma Research, The University of Texas MD Anderson Cancer Center
- 2021 Potu N. Rao Award for Excellence in Basic Science, The University of Texas MD Anderson Cancer Center
- 2009 Elected to American Society for Clinical Investigation
- 2006-2012 Clinical Scientist Award in Translational Research, Burroughs Wellcome Fund
- 2001-2006 Damon Runyon-Lilly Foundation, Clinical Investigator Award, Damon Runyon-Lilly Foundation
Clinical Focus
Subspecialties
Conditions & Treatments
Practice Details
Hospital Affiliations
- University of Texas MD Anderson Cancer Center
Languages
English
Experience
40+ years in practice